News about companies, funding, investing in equity
Promethera Biosciences
Promethera Biosciences SA, a Mont, Saint Guibert, Belgium-based cell therapy and regenerative medicine company targeting liver diseases, raised €10m ($11m) in Series C financing.
Backers included existing shareholders Vesalius Biocapital, SRIW, Fund+, MGI Global Fund (Mitsui & Co), Boehringer Ingelheim Venture Fund and SMS Investments and new investors Mitsubishi UFJ Capital Co., Ltd. and Cell Innovation Partners, L.P. (CIP) from Japan and LifeLiver Co., Ltd. from South Korea


